Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-020467
Filing Date
2025-02-14
Accepted
2025-02-14 08:52:59
Documents
106
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apvo-20241231.htm   iXBRL 10-K 3718467
2 EX-19.1 apvo-ex19_1.htm EX-19.1 96141
3 EX-21.1 apvo-ex21_1.htm EX-21.1 8959
4 EX-23.1 apvo-ex23_1.htm EX-23.1 10901
5 EX-31.1 apvo-ex31_1.htm EX-31.1 16786
6 EX-31.2 apvo-ex31_2.htm EX-31.2 16826
7 EX-32.1 apvo-ex32_1.htm EX-32.1 10746
8 EX-32.2 apvo-ex32_2.htm EX-32.2 10969
9 EX-97 apvo-ex97.htm EX-97 39807
10 GRAPHIC img135512644_0.jpg GRAPHIC 199177
11 GRAPHIC img135512644_1.jpg GRAPHIC 250435
12 GRAPHIC img135512644_2.jpg GRAPHIC 300675
13 GRAPHIC img135512644_3.jpg GRAPHIC 274725
14 GRAPHIC img135512644_4.jpg GRAPHIC 18628
15 GRAPHIC img135512644_5.jpg GRAPHIC 16439
16 GRAPHIC img135512644_6.jpg GRAPHIC 7623
17 GRAPHIC img135512644_7.jpg GRAPHIC 7623
18 GRAPHIC img135512644_8.jpg GRAPHIC 11751
19 GRAPHIC img135512644_9.jpg GRAPHIC 7623
20 GRAPHIC img135512644_10.jpg GRAPHIC 7623
21 GRAPHIC img135512644_11.jpg GRAPHIC 7623
  Complete submission text file 0000950170-25-020467.txt   14742252

Data Files

Seq Description Document Type Size
22 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20241231.xsd EX-101.SCH 1685233
109 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20241231_htm.xml XML 1529010
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37746 | Film No.: 25623597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)